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With growing fear of a worldwide influenza pandemic, programs that can rapidly vaccinate
a broad range of persons are urgently needed. Vaccination rates are low among disadvan-
taged and hard-to-reach populations living within urban communities, and delivering vac-
cines to these groups may prove challenging. Project VIVA1 (Venue-Intensive Vaccination
for Adults), staffed by teams of nurses and outreach workers, aimed to deliver vaccines rap-
idly within disadvantaged neighborhoods in New York City. Project VIVA nurses offered
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free influenza vaccine door-to-door and on street corners over 10 days in October, 2005. A
total of 1,648 people were vaccinated, exceeding expectation. Careful selection and training
of project staff, community involvement in project development, community outreach, and
prioritizing street-based distribution may be key factors in an effective rapid vaccination
program. In conclusion, this project may be replicated in other communities and utilized for
annual vaccination campaigns and in the event of a pandemic.
With increasing concerns about the threat of a human influenza pandemic, there is
mounting pressure for public health officials to identify new and effective methods to
rapidly deliver vaccines to large numbers of people (Cinti, 2005). Community health
nurses are likely to play a vital role during a pandemic, including involvement in mass
vaccination efforts (Ho & Parker, 2006). Although there have been a number of
replicable vaccination interventions (D’Heilly, Lockman, & Nichol, 2004; Osterholm,
2001; Poland, Grabenstein, & Neff, 2005), examples of programs providing rapid vacci-
nations to hard-to-reach populations (e.g., substance users, elderly shut-ins, homeless)
are limited (Weatherill, Buxton, & Daly, 2004). The recent failure of the smallpox vacci-
nation program among US health care workers, a population that should be receptive to
vaccination and highly accessible, highlights the challenges in conducting mass vaccina-
tion campaigns (Kuhles & Ackman, 2003).
A variety of approaches have been employed to improve vaccination coverage, includ-
ing provider education (Findley et al., 2003); patient education, incentives, and remind-
ers (Hoekstra et al., 1998; Krieger, Castorina, Walls, Weaver, & Ciske, 2000); and provi-
sion of vaccines in settings serving high risk populations, including hospital emergency
departments (Slobodkin, Kitlas, & Zielske, 1998) and syringe exchange sites (Des Jarlais
et al., 2001; Stancliff, Salomon, Perlman, & Russell, 2000). Low vaccination coverage
among minorities and other hard-to-reach populations remains a persistent problem,
however. Unvaccinated groups within a larger population may propagate disease, partic-
ularly in the event of a pandemic (Centers for Disease Control and Prevention, 2003;
Egede & Zheng, 2003; Kuo, Sherman, Thomas, & Strathdee, 2004).
Building on the lessons learned from the previously-described efforts, Project VIVA
was a community-based demonstration project designed to evaluate the feasibility of a
rapid vaccination protocol for hard-to-reach populations that could serve as a model for
pandemic preparedness plans. For the purposes of this project, hard-to-reach populations
included substance users, elderly, undocumented immigrants, the homeless, and com-
mercial sex workers. This community-based intervention, in which community nurses
offered door-to-door and street-based vaccinations, successfully delivered 1,648 influ-
enza vaccines in low-income communities of New York City in October, 2005. Here, we
describe the project, highlighting the central role played by community-based nurses, to
demonstrate its feasibility and outline lessons learned that may guide project replication
in other venues.
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PROGRAM DESCRIPTION
Start-Up
The demonstration project described here was developed and implemented by a re-
search-community partnership, the Harlem Community and Academic Partnership,
which includes researchers at the Center for Urban Epidemiologic Studies, The New
York Academy of Medicine (NYAM). The overall goals of Project VIVA were (a) assess-
ment of personal and structural barriers to immunization; (b) examination of the feasibil-
ity, acceptance, and utility of a community-public health partnership as a framework for
rapid vaccination of hard-to-reach populations; (c) development, implementation, and
assessment of a rapid vaccination protocol for hard-to-reach and high-risk populations
that could contribute to pandemic influenza preparedness plans; and (d) generalizing this
effort to other hard-to-reach populations in other urban areas.
During the first year of implementation, VIVA staff conducted extensive outreach to
community members, organizations, and leaders. Outreach workers handed out over
28,000 informational flyers on street corners and delivered 19 presentations at commu-
nity-based organizations. Staff members also conducted outreach to local community
leaders working in housing, HIV/AIDS, needle exchange, and other service delivery pro-
grams. Community leaders were invited to participate in relevant project meetings and
asked to disseminate project information.
During the first year of the project, those involved also developed methods for enu-
merating hard-to-reach populations in target neighborhoods and carried out surveys to
examine key personal and structural barriers to local vaccination. The survey instrument
assessed (a) sociodemographic characteristics, including age, gender, race, and educa-
tion domains; (b) characteristics that may be associated with social marginalization, in-
cluding substance abuse and commercial sex work; (c) access to and utilization of health
care; (d) vaccination history; (e) general health; and (f) trust in government and social
agencies. The anonymous, cross-sectional survey lasted approximately 5 min. and was
administered on the street or in apartment buildings in both English and Spanish.
As reported in a prior publication (Bryant et al., 2006), people involved in the project
found that those who did not regularly utilize health or social services and those without
government-sponsored health insurance were less likely to have been vaccinated. If vac-
cine was available, however, these individuals would be willing to receive it.
Nurses provided vaccination with influenza vaccine to a limited number of individuals
in the start-up phase, to assess likely acceptance of vaccination in these neighborhoods
during the second year of the project. The rapid vaccination phase of the intervention de-
scribed here was carried out in Year 3, when the project aimed to deliver 1500 vaccines to
persons within four specific communities of New York City during 10 working days.
Years 4 and 5 are devoted to dissemination of project findings.
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Rapid Vaccine Distribution
Eight nurses were hired through a temporary nursing staffing agency to administer the
vaccinations during the 10-day distribution phase (see Figure 1). Four bilingual (English/
Spanish) field supervisors were hired for a 2-month period to manage the outreach ef-
forts, and 12 outreach workers were hired for 1 month to administer brief door-to-door
and street-based surveys. All staff participated in a 2-day training covering study proto-
col, outreach role-plays, and the clinical aspects of the study (eligibility criteria, vaccine
distribution, and handling adverse events). The project staff publicized the rapid vaccine
effort by posting flyers that noted locations, dates, and times of vaccine distribution, and
through presentations about the project at community meetings.
A team of two nurses, one field supervisor, and three outreach workers were as-
signed to each community (6–8 city blocks in size). Vaccines were offered
door-to-door within apartment buildings and on the street. Members of the field staff
were responsible for approaching potential participants, obtaining consent, and admin-
istering the study questionnaire. Vaccine eligibility was determined based on influenza
vaccine guidelines; in addition, participants had to be ≥ 19 years of age and not preg-
nant. Participants were vaccinated by the nurses while sitting on a portable seat
brought to the field each day.
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FIGURE 1 Project VIVA Rapid Vaccination Timeline.
Adverse Events
A detailed protocol was developed to handle adverse events, although none occurred.
Staff members were assigned specific responsibilities (e.g., if warranted, nurses would
administer epinephrine or Benadryl and maintain an airway; outreach workers would call
911 and wait for the ambulance). The medical director of the study, a physician, was on
call at all times, and a licensed nurse managed all aspects of the program. Adverse events
would have been reported to the NYAM Institutional Review Board and to the Vaccine
Adverse Event Reporting System.
Flu vaccine was delivered to a total of 1,648 persons during the 10-day distribution
phase, exceeding expectation. Almost half (47%) of those vaccinated were members of a
hard-to-reach population.
LESSONS LEARNED
This project demonstrated the feasibility of rapid vaccination of urban populations by
community-based nurses. Overwhelmingly, reactions to the project were positive in the
local communities and community members were eager to receive the vaccine. During
the vaccination effort, the contact number provided on the publicity flyers yielded over
100 calls per week, indicative of the high level of community interest.
The project was originally designed to focus primarily on door-to-door vaccination;
however, project staff quickly found door-to-door distribution to be relatively inefficient.
Three visits were made to each apartment (on different days and at different times of the
day) in an attempt to reach as many people as possible; however, vaccination rates were
relatively low due to the number of people not at home during working hours and due to
refusals. In contrast, field staff on the street, recognizable through their bright yellow
Project VIVA jackets, were consistently approached by crowds of people interested in re-
ceiving the vaccine. Street-based distribution proved to be a very effective way to vacci-
nate large numbers of people in a brief time, and this method was given priority. Lines (up
to 50 persons long) formed quickly for street-based distribution, although waiting time
never exceeded 30 min. The extent to which a particular mode of distribution was more
effective for reaching specific vulnerable populations is still to be determined.
Although the aim of this project was to target hard-to-reach populations, project staff
distributed vaccine to all interested and eligible persons in the targeted neighborhoods, ir-
respective of individual characteristics. Because the neighborhoods were low-income
and much of the resident population lacked ready access to health care services, wide-
spread distribution was warranted. In addition, the community-based methods—and the
attention they garnered—contributed to improved access to hard-to-reach populations,
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and the resultant high percentage of vaccines being distributed to members of these
groups.
Project staffing, training, and support, including the selection of nurses and outreach
staff with complementary research skills and personal knowledge of the community,
were key to project success. Community oversight of project development and imple-
mentation was essential, and greatly enhanced receptivity to the project. Project success
was also facilitated by the community partnership’s direction of the extensive outreach
effort, both within the first 2 years of the study and immediately prior to the rapid vacci-
nation phase, which allowed project staff and community members to become familiar
with one another.
IMPLICATIONS FOR OTHER RAPID VACCINATION PROGRAMS
Developing strategies for vaccinating hard-to-reach populations in the event of an influ-
enza pandemic is a priority in current federal preparedness plans. To best prepare the
community for the eventuality of a pandemic, instituting annual mass flu vaccination
campaigns in street-based nontraditional settings is recommended. Utilizing a commu-
nity-based approach in project development and implementation will facilitate increased
awareness and receptivity and maximize the success of the program. Outreach activities
focused on promoting visibility and trust, including the obvious involvement of commu-
nity nurses, should also be an integral part of this effort. Based on experience, this dem-
onstration project, with nurses in a central community-based vaccine distribution role,
has the potential to be generalized to other hard-to-reach populations in other areas, and
utilized both for annual vaccination campaigns, and in the event of an influenza pan-
demic.
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